Top 5 Health Care Stocks That Are Preparing To Pump In November
Top 5 Health Care Stocks That Are Preparing To Pump In November
Read More: Fear & Greed Index Remains In 'Fear' Zone; Dow Notches Best Day Since June The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
医疗保健领域超卖次数最多的股票为买入被低估的公司提供了机会。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.
RSI是一种动量指标，它比较了股票在价格上涨的日子里的强度与价格下跌时的强度。与股票的价格走势相比，它可以让交易者更好地了解股票在短期内的表现。当 RSI 低于 30 时，资产通常被视为超卖。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是该行业主要超卖参与者的最新名单，RSI接近或低于30。
Better Therapeutics Inc (NASDAQ:BTTX)
Better Therapeut （纳斯达克股票代码：BTTX）
- Better Therapeutics recently announced the launch of AspyreRxTM to treat adults with Type 2 diabetes. The company's stock has a 52-week low of $0.14 .
- RSI Value: 27.85
- BTTX Price Action: Shares of Better Therapeutics fell 6.1% to close at $0.15 on Thursday.
- Better Therapeutics最近宣布推出AspyrerXTM，用于治疗成人 2 型糖尿病。该公司的股票有一个 52 周低点为 0.14 美元 。
- RSI 值： 27.85
- BTTX 价格走势： 周四，Better Therapeutics的股价下跌6.1％，收于0.15美元。
Heart Test Laboratories Inc (NASDAQ:HSCS)
心脏测试实验室公司 （纳斯达克股票代码：HSCS）
- On Sept. 18, Heart Test Laboratories entered into an equity distribution agreement with Maxim Group as sales agent. It has a 52-week low of $0.20.
- RSI Value: 26.80
- HSCS Price Action: Shares of Heart Test Laboratories fell 8.2% to close at $0.21 on Thursday.
- 9月18日，心脏测试实验室与作为销售代理的Maxim集团签订了股权分配协议。它 创下 52 周低点 0.20 美元的。
- RSI 值： 26.80
- HSCS 价格走势： 周四，心脏测试实验室股价下跌8.2％，收于0.21美元。
SINTX Technologies Inc (NASDAQ:SINT)
SINTX 科技公司 （纳斯达克股票代码：SINT）
- SINTX Technologies was awarded Phase II NIH grant of $1,972,826 for silicon nitride-PEEK 3D printed composite spinal implants. The company's stock has a 52-week low of $0.40.
- RSI Value: 28.18
- SINT Price Action: Shares of SINTX Technologies fell 6.9% to close at $0.42 on Thursday.
- SINTX Technologies获得了美国国立卫生研究院第二阶段拨款1,972,826美元，用于购买氮化硅Peek 3D打印的复合脊柱植入物。该公司的股票有效期为52周 低点为0.40美元。
- RSI 值： 28.18
- SINT 价格走势： 周四，SINTX Technologies的股价下跌6.9％，收于0.42美元。
Evelo Biosciences Inc (NASDAQ:EVLO)
伊维洛生物科学公司 （纳斯达克股票代码：EVLO）
- Evelo Biosciences reported the primary endpoint in its Phase 2 clinical study with EDP2939 in moderate psoriasis was not achieved. The company also initiated a process to explore strategic alternatives. The company's 52-week low is $0.30.
- RSI Value: 15.98
- EVLO Price Action: Shares of Evelo Biosciences fell 19.4% to close at $0.31 on Thursday.
- Evelo Biosciences报告称，其针对中度牛皮癣的 EDP2939 2期临床研究的主要终点未达到。该公司还启动了探索战略替代方案的进程。该公司的52周低点为0.30美元。
- RSI 值： 15.98
- EVLO 价格走势： 周四，Evelo Biosciences的股价下跌19.4％，收于0.31美元。
Arcutis Biotherapeutics Inc (NASDAQ:ARQT)
Arcutis 生物疗法公司 （纳斯达克股票代码：ARQT）
- Arcutis Biotherapeutics announced the pricing of a $100 million public offering of 32.5 million common shares at $2.50 per share. The company has a 52-week low of $2.13.
- RSI Value: 21.70
- ARQT Price Action: Shares of Arcutis Biotherapeutics fell 1.8% to close at $2.22 on Thursday.
- Arcutis Biotherapeutics宣布公开发行3,250万股普通股的1亿美元，定价为每股2.50美元。该公司 创下 52 周低点 2.13 美元。
- RSI 值： 21.70
- ARQT 价格走势： 周四，Arcutis Biotherapeutics的股价下跌1.8％，收于2.22美元。
Read More: Fear & Greed Index Remains In 'Fear' Zone; Dow Notches Best Day Since June
阅读更多： 恐惧与贪婪指数仍处于 “恐惧” 区域；道琼斯指数创下6月以来的最佳日子
